UK - GlaxoSmithKline's £900m ($1.5bn) buy-in deal last year would not have been possible without transition managers, said Martin Mannion, director of pensions finance, investments and risk.
GSK entered into a buy-in deal with Prudential in November of last year. (Global Pensions; 16 November 2010) Speaking at a recent transition management debate hosted by Global Pensions, Mannion ...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
